All in the CCN family: Essential matricellular signaling modulators emerge from the bunker

Journal of Cell Science

Volumn 119, Issue 23, 2006, Pages 4803-4810

  Leask, Andrew ^a   Abraham, David J ^b  

^a WESTERN UNIVERSITY   (Canada)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

CCN1; CCN2; CCN3; Connective tissue growth factor; Integrins; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; CCN PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; CYTOKINE; ENDOTHELIN 1; GROWTH FACTOR; INTEGRIN; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PROTEIN SUBUNIT; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WISP 1 PROTEIN; WISP 2 PROTEIN; WISP 3 PROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER; CELL ADHESION; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CHONDROGENESIS; CONNECTIVE TISSUE DISEASE; EXTRACELLULAR MATRIX; FIBROGENESIS; FIBROSIS; FOCAL ADHESION; GENE CONTROL; HUMAN; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TISSUE REPAIR; VASCULAR DISEASE;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CYSTEINE-RICH PROTEIN 61; CYTOKINES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTEGRINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOGENESIS; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 33845906843     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03270     Document Type: Article

References (117)

1. Abraham, D. J., Shiwen, X., Black, C. M., Sa, S., Xu, Y. and Leask, A. (2000). Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. 275, 15220-15225.
2. Abreu, J. G., Ketpura, N. L, Reversade, B. and De Robertis, E. M. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 4, 599-604.
3. Aikawa, T., Gunn, J., Spong, S. M., Klaus, S. J. and Korc, M. (2006). Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol. Cancer Ther. 5, 1108-1116.
4. Asano, M., Kubota, S., Nakanishi, T., Nishida, T., Yamaai, T., Yosimichi, G., Ohyama, K., Sugimoto, T., Murayama, Y. and Takigawa, M. (2005). Effect of connective tissue growth factor (CCN2/CTGF) on proliferation and differentiation of mouse periodontal ligament-derived cells. Cell Commun. Signal. 3, 11.
5. Babic, A. M., Kireeva, M. L., Kolesnikova, T. V. and Lau, L. F. (1998). CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95, 6355-6360.
6. Babic, A. M., Chen, C. C. and Lau, L. F. (1999). Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. 19, 2958-2966.
7. Bartholin, L., Wessner, L. L., Chirgwin, J. M. and Guise, T. A. (2006). The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. Cancer Lett. doi: 10. 1016/ j.canlet.2006.02.019
8. Blom, I. E., van Dijk, A. J., Wieten, L., Duran, K., Ito, Y., Kleij, L., de Nichilo, M., Rabelink, T. J., Weening, J. J., Aten, J. et al. (2001). In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol. Dial. Transplant. 16, 1139-1148.
9. Blom, I. E., Goldschmeding, R. and Leask, A. (2002). Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol. 21, 473-482.
10. Bonniaud, P., Margetts, P. J., Kolb, M., Haberberger, T., Kelly, M., Robertson, J. and Gauldie, J. (2003). Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am. J. Respir Crit. Care Med. 168, 770-778.
11. Bonniaud, P., Martin, G., Margetts, P. J., Ask, K., Robertson, J., Gauldie, J. and Kolb, M. (2004). Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am. J Respir Cell Mol. Biol. 31, 510-516.
12. Bork, P. (1993). The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327, 125-130.
13. Bradham, D. M., Igarashi, A., Potter, R. L. and Grotendorst, G. R. (1991). Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114, 1285-1294.
14. Brigstock, D. R., Steffen, C. L., Kim, G. Y., Vegunta, R. K., Diehl, J. R. and Harding, P. A. (1997). Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol. Chem. 272, 20275-20282.
15. Brigstock, D. R., Goldschmeding, R., Katsube, K. I., Lam, S. C., Lau, L. F., Lyons, K., Naus, C., Perbal, B., Riser, B., Takigawa, M. et al. (2003). Proposal for a unified CCN nomenclature. Mol. Pathol. 56, 127-128.
16. Chen, C. C., Mo, F. E. and Lau, L. F. (2001). The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J. Biol. Chem. 276, 47329-47337.
17. Chen, N., Chen, C. C. and Lau, L. F. (2000). Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans. J. Biol. Chem. 275, 24953-24961.
18. Chen, N., Leu, S. J., Todorovic, V., Lam, S. C. and Lau, L. F. (2004). Identification of a novel integrin alphavbeta-3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J. Biol. Chem. 279, 44166-44176.
19. Chen, Y., Segarini, P., Raoufi, F., Bradham, D. and Leask, A. (2001). Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome Exp. Cell Res. 271, 109-117.
20. Chen, Y., Blom, I. E., Sag S., Goldschmeding, R., Abraham, D. J. and Leask, A. (2002). CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 62, 1149-1159.
21. Chen, Y., Abraham, D. J., Shi-Wen, X., Pearson, J. D., Black, C. M., Lyons, K. M. and Leask, A. (2004). CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol. Biol. Cell 15, 5635-5646.
22. Chen, Y., Shi-wen, X., Eastwood, M., Black, C. M., Denton, C. P., Leask, A. and Abraham, D. J. (2006). Contribution of activin receptor-like kinase 5 (transforming growth factor betareceptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum. 54, 1309-1316.
23. Crean, J. K., Furlong, F., Finlay, D., Mitchell, D., Murphy, M., Conway, B., Brady, H. R., Godson, C. and Martin, F. (2004). Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. FASEB J. 18, 1541-1543.
24. Desnoyers, L., Arnott, D. and Pennica, D. (2001). WISP-1 binds to decorin and biglycan. J Biol. Chem. 276, 47599-47607.
25. Dziadzio, M., Usinger, W., Leask, A., Abraham, D., Black, C. M., Denton, D. and Stratton, R. (2005). N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM 98, 485-492.
26. Ellis, P. D., Metcalfe, J. C., Hyvonen, M. and Kemp, P. R. (2003). Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5betal. J. Vasc. Res. 40, 234-243.
27. Fataccioli, V., Abergel, V., Wingertsmann, L., Neuville, P., Spitz, E., Adnot, S., Calenda, V. and Teiger, E. (2002). Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate. Hum. Gene Ther. 13, 1461-1470.
28. French, D. M., Kaul, R. J., D'Souza, A. L., Crowley, C. W., Bao, M. Frantz, G. D., Filaroff, E. H. and Desnoyers, L. (2004). WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am. J. Pathol. 165, 855-867.
29. Fu, C. T., Bechberger, J. F., Ozog, M. A., Perbal, B. and Natts, C. C. (2004). CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J. Biol. Chem. 279, 36943-36950.
30. Gao, R. and Brigstock, D. R. (2003). Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol. Res. 27, 214-220.
31. Gao, R. and Brigstock, D. R. (2004). Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J. Biol. Chem. 279, 8848-8855.
32. Goo, R., Ball, D. K., Perbal, B. and Brigstock, D. R. (2004). Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J. Hepatol. 40, 431-438.
33. Gellhaus, A., Dong, X., Propson, S., Maass, K., Klein-Hitpass, L., Kibschull, M., Traub, O., Willecke, K., Perbal, B., Lye, S. J. et al. (2004). Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol. Chem. 279, 36931-36942.
34. Gery, S., Xie, D., Yin, D., Gabra, H., Miller, C., Wang, H., Scott, D., Yi, W. S., Popoviciu, M. L., Said, J. W. et al. (2005). Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin. Cancer Res. 11, 7243-7254.
35. Gore-Hyer, E., Pannu, J., Smith, E. A., Grotendorst, G. and Trojanowska, M. (2003). Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts. Arthritis Rheum. 48, 798-806.
36. Grotendorst, G. R. (1997). Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8, 171-179.
37. Grotendorst, G. R. and Duncan, M. R. (2005). Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 19, 729-738.
38. Grotendorst, G. R., Okochi, H. and Hayashi, N. (1996). A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7, 469-490.
39. Grotendorst, G. R., Rahmanie, H. and Duncan, M. R. (2004). Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 18, 469-479.
40. Gupta, N., Wang, H., McLeod, T. L., Naus, C. C., Kyurkchiev, S., Advani, S., Yu, J., Perbal, B. and Weichselbaum, R. R. (2001). Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol. Pathol. 54, 293-299.
41. Higgins, D. F., Biju, M. P., Akai, Y., Wutz, A., Johnson, R. S. and Haase, V. H. (2004). Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Physiol. Renal Phvsiol. 287, F1223-F1232.
42. Holloway, S. E., Beck, A. W., Girard, L., Jaber, M. R., Barnett, C. C., Jr, Brekken, R. A. and Fleming, J. B. (2005). Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J. Am. Coll. Surg. 200, 371-377.
43. Holmes, A., Abraham, D. J., Sa, S., Shiwen, X., Black, C. M. and Leask, A. (2001). CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem. 276, 10594-10601.
44. Holmes, A., Abraham, D. J., Chen, Y., Denton, C., Shi-wen, X., Black, C. M. and Leask, A. (2003). Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J. Biol. Chem. 278, 41728-41733.
45. Hoshijima, M., Hattori, T., Inoue, M., Araki, D., Hanagata, H., Miyauchi, A. and Takigawa, M. (2006). CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett. 580, 1376-1382.
46. Hurvitz, J. R., Suwairi, W. M., Van Hul, W., El-Shanti, H., Superti-Furga, A., Roudier, J., Holderbaum, D., Pauli, R. M., Herd, J. K., Van Hul, E. V. et al. (1999). Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 23, 94-98.
47. Igarashi, A., Okochi, H., Bradham, D. M. and Grotendorst, G. R. (1993). Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell 4, 637-645.
48. Inoki, I., Shiomi, T., Hashimoto, G., Enomoto, H., Nakamura, H., Makino, K., Ikeda, E., Takata, S., Kobayashi, K. and Okada, Y. (2002). Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 16, 219-221.
49. Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda de Stephenson, R. C., Daluiski, A. and Lyons, K. M. (2003). Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130, 2779-2791.
50. Jedsadayanmata, A., Chen, C. C., Kireeva, M. L., Lau, L. F. and Lam, S.C. (1999). Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J. Biol. Chem. 274, 24321-24327.
51. Joliot, V., Martinerie, C., Dambrine, G., Plassiart, G., Brisac, M., Crochet, J. and Perbal, B. (1992). Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol. Cell. Biol. 12, 10-21.
52. Kireeva, M. L., Mo, F. E., Yang, G. P. and Lau, L. F. (1996). Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol. Cell. Biol. 16, 1326-1334.
53. Kireeva, M. L., Latinkic, B. V., Kolesnikova, T. V., Chen, C. C., Yang, G. P., Abler, A. S. and Lau, L. F. (1997). Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp. Cell Res. 233, 63-77.
54. Kireeva, M. L., Lam, S. C. and Lau, L. F. (1998). Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J Biol. Chem. 273, 3090-3096.
55. Kondo, S., Kubota, S., Mukudai, Y., Moritani, N., Nishida, T., Matsushita, H., Matsumoto, S., Sugahara, T. and Takigawa, M. (2006). Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3′-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene 25, 1099-1110.
56. Kubota, S., Kondo, S., Eguchi, T., Hattori, T., Nakanishi, T., Pomerantz, R. J. and Takigawa, M. (2000). Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 ctgf/hcs24) gene: similarities to retroviral RNA-protein interactions. Oncogene 19, 4773-4786.
57. Kutz, W. E., Gong, Y. and Warman, M. L. (2005). WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice. Mol. Cell. Biol. 25, 414-421.
58. Lafont, J., Laurent, M., Thibout, H., Lallemand, F., Le Bone, Y., Atfi, A. and Martinerie, C. T. (2002). The expression of novH in adrenocortical cells is down-regulated by TGFbeta I through c-Jun in a Smad-independent manner. J. Biol. Chem. 277, 41220-41229.
59. Lafont, J., Thibout, H., Dubois, C., Laurent, M. and Martinerie, C. (2005a). NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-I to promote proliferation and survival. Cell Commun. Adhes. 12, 41-57.
60. Lafont, J., Jacques, C., Le Dreau, G., Calhabeu, F., Thibout, H., Dubois, C. F., Laurent, M. and Martinerie, C. (2005b). New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen. J Bone Miner Res. 20, 2213-2223.
61. Latinkic, B. V., Mo, F. E., Greenspan, J. A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Ross, S. R. and Lau, L. F. (2001). Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: tissue specificity, inducibility during wound healing, and role of the serum response element. Endocrinology 142, 2549-2557.
62. Latinkic, B. V., Mercurio, S., Bennett, B., Hirst, E. M., Xu, Q., Lau, L. F., Mohun, T. J. and Smith, J. C. (2003). Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signaling. Development 130, 2429-2441.
63. Leask, A. and Abraham, D. J. (2003). The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem. Cell Biol. 81, 355-363.
64. Leask, A. and Abraham, D. J. (2004). TGF-beta signaling and the fibrotic response. FASEB J. 18, 816-827.
65. Leask, A., Sa, S., Holmes, A., Shiwen, X., Black, C. M. and Abraham, D. J. (2001). The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol. Pathol. 54, 180-183.
66. Leask, A., Holmes, A., Black, C. M. and Abraham, D. J. (2003). Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol. Chem. 278, 13008-13015.
67. Lechner, A., Schutze, N., Siggelkow, H., Seufert, J. and Jakob, F. (2000). The immediate early gene product hCYR61 localizes to the secretory pathway in human osteoblasts. Bone 27, 53-60.
68. Leu, S. J., Lam, S. C. and Lau, L. F. (2002). Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J. Biol. Chem. 277, 46248-46255.
69. Leu, S. J., Liu, Y., Chen, N., Chen, C. C., Lam, S. C. and Lau, L. F. (2003). Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61). J Biol. Chem. 278, 33801-33808.
70. Leu, S. J., Chen, N., Chen, C. C., Todorovic, V., Bai, T., Juric, V., Liu, Y., Yan, G., Lam, S. C. and Lau, L. F. (2004). Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions. J. Biol. Chem. 279, 44177-44187.
71. Li, C. L., Martinez, V., He, B., Lombet, A. and Perbal, B. (2002). A role for CCN3 (NOV) in calcium signaling. Mol. Pathol. 55, 250-261.
72. Ling C. G., Leu, S. J., Chen, N., Tebeau, C. M., Lin, S. X., Yeung, C. Y. and Lau, L. F. (2003). CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J. Biol. Chem. 278, 24200-24208.
73. Lin, C. G., Chen, C. C., Len, S. J., Grzeszkiewicz, T. M. and Lau, L. F. (2005). Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J. Biol. Chem. 280, 8229-8237.
74. Lin, M. T., Zuon, C. Y., Chang, C. C., Chen, S. T., Chen, C. P., Lin, B.R., Wang, M. Y., Jeng, Y. M., Chang, K. J., Lee, P. H. et al. (2005b). Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor kappaB/cyclooxygenase-2 signaling pathway. Clin. Cancer Res. 11, 5809-5820.
75. Mason, H. R., Lake, A. C., Wubben, J. E., Nowak, R. A. and Castellot, J.J., Jr (2004). The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol. Hum. Reprod. 10, 181-187.
76. Menendez, J. A., Mehmi, L, Griggs, D. W. and Lupu, R. (2003). The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. Endocr. Relat. Cancer 10, 141-152.
77. Mercurio, S., Latinkic, B., Itasaki, N., Krumlauf, R. and Smith, J. C. (2004). Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131, 2137-2147.
78. Mo, F. E., Muntean, A. G., Chen, C. C., Stolz, D. B., Watkins, S. C. and Lau, L. F. (2002). CYR61 (CCN1) is essential for placental development and vascular integrity Mol. Cell. Biol. 22, 8709-8720.
79. Mori, T., Kawara, S., Shinozaki, M., Hayashi, N., Kakinuma, T., Igarashi, A., Takigawa, M., Nakanishi, T. and Takehara, K. J. (1999). Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J. Cell. Physiol. 181, 153-159.
80. Nakanishi, T., Nishida, T., Shimo, T., Kobayashi, K., Kubo, T., Tamatani, T., Tezuka, K. and Takigawa, M. (2000). Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, an the proliferation and differentiation of chondrocytes in culture. Endocrinology 141, 264-273.
81. Nakanishi, T., Yamaai, T., Asano, M., Nawachi, K., Suzuki, M., Sugimoto, T. and Takigawa, M. (2001). Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism. Biochem. Biophys. Res. Commum. 281, 678-681.
82. Nakata, E., Nakanishi, T., Kawai, A., Asaumi, K., Yamaai, T., Asano, M., Nishida, T., Milani, S., Inoue, H. and Takigawa, M. (2002). Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24) during fracture healing. Bone 31, 441-447.
83. Nguyen, T. Q., Tarnow, L., Andersen, S., Hovind, P., Parving, H. H., Goldschmeding, R. and van Nieuwenhoven, F. A. (2006). Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 29, 83-88.
84. Nishida, T., Nakanishi, T., Asano, M., Shimo, T. and Takigawa, M. (2000). Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J. Cell. Physiol. 184, 197-206.
85. Nishida, T., Kubota, S., Fukunaga, T., Kondo, S., Yosimichj, G., Nakanishi, T., Takano-Yamamoto, T. and Takigawa, M. (2003). CTGF/Hcs24, bypertrophic chondrocyte-specific gene product, interacts with perlecan in regulating the proliferation and differentiation of chondrocytes. J. Cell. Physiol. 196, 265-275.
86. O'Brien, T. P., Yang, G. P., Sanders, I. and Lau, L. F. (1990). Expression of cyr61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10, 3569-3577.
87. Ott, C., Iwanciw, D., Graness, A., Giehl, K. and Goppelt-Struebe, M. (2003). Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton. J Biol. Chem. 278, 44305-44311.
88. Parisi, M. S., Gazzerro, E., Rydziel, S. and Canalis, E. (2006). Expression and regulation of CCN genes in routine osteoblasts. Bone 38, 671-677.
89. Pennica, D., Swanson, T. A., Welsh, J. W., Roy, M. A., Lawrence, D. A., Lee, J., Brush, J., Taneyhill, L. A., Deuel, B., Lew, M. et al. (1998). WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95, 14717-14722.
90. Perbal, B. (2004). CCN proteins: multifunctional signalling regulators. Lancet 363, 62-64.
91. Perbal, B. and Takigawa, M. (ed.) (2005). CCN Proteins: A New Family of Cell Growth And Differentiation Regulators. London: World Scientific Publishers.
92. Rachfal, A. W., Luquette, M. H. and Brigstock, D. R. (2004). Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour. J. Clin. Pathol. 57, 422-425.
93. Rodriguez-Pascual, F., Redondo-Horcajo, M. and Lamas, S. (2003). Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. Circ. Res. 92, 1288-1295.
94. Sakamoto, K., Yamaguchi, S., Ando, R., Miyawaki, A., Kabasawa, Y, Takagi, M., Li, C. L., Perbal, B. and Katsube, K. (2002). The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J. Biol. Chem. 277, 29399-29405.
95. Sakamoto, S., Yokoyama, M., Aoki, M., Suzuki, K., Kakehi, Y. and Saito, Y. (2004). Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation. Prostate 61, 305-317.
96. Schober, J. M., Lau, L. E, Ugarova, T. P. and Lam, S. C. (2003). Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. J. Biol. Chem. 278, 25808-25815.
97. Schutze, N., Noth, U., Schneidereit, J., Hendrich, C. and Jakob, F. (2005). Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation Cell Commun. Signal. 3, 5.
98. Segarini, P. R., Nesbitt, J. E., Li, D., Hays, L. G., Yates, J. R, 3rd and Carmichael, D. F. (2001). The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J. Biol. Chem. 276, 40659-40667.
99. Sen, M., Cheng, Y. H., Goldring, M. B., Lotz, M. K. and Carson, D. A. (2004). AWISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum. 50, 488-497.
100. Shimo, T., Nakanishi, T., Nishida, T., Asano, M., Kanyama, M., Kuboki, T., Tamatani, T., Tezuka, K., Takemura, M., Matsumura, T. et al. (1999). Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem. 126, 137-145.
101. Shimo, T., Kubota, S., Yoshioka, N., Ibaragi, S., Isowa, S., Eguchi, T., Sasaki, A. and Takigawa, M. (2006). Pathogenic role of Connective Tissue Growth Factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res. 21, 1045-1059.
102. Shi-wen, X., Howat, S. L., Renzoni, E. A., Holmes, A., Pearson, J. D., Dashwood, M. R., Bou-Gharios, G., Denton, C. F., do Bois, R. M., Black, C. M. et al. (2004). Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol. Chem. 279, 23098-23103.
103. Shi-wen, X., Stanton, L., Kennedy, L., Chen, Y., Pala, D., Chen, Y., Howat, S. L., Renzoni, E. A., Carter de Bou-Gharios, G., Stratton, R. J. et al. (2006a). CCN2 is necessary for adhesive responses to TGFβ1 in embryonic fibroblasts. J Biol. Chem. 281, 10715-10726.
104. Shi-wen, X., Rodrigues-Pascual, F., Lamas, S., Holmes, A., Howat, S., Pearson, J. D., Dashwood, M. R., do Bois, R. M., Denton, C. P., Black, C. M. et al. (2006b). Constitutive ALK5-indepenent JNK activation contributes to endothelin-1 over-expression in pulmonary fibrosis. Mol. Cell. Biol. 26, 5518-5527.
105. Si, W., Kang, Q., Lou, H. H., Park, J. K., Luo, Q., Song, W. X., Jiang, W., Lao, X., Li, X., Yin, H. et al. (2006). CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell. Biol. 26, 2955-2964.
106. Stratton, R., Rajkumar, V., Ponticos, M., Nichols, B., Shiwen, X., Black, C. M., Abraham, D. J. and Leask, A. (2002). Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway. FASEB J. 16, 1949-1951.
107. Takigawa, M., Nakanishi, T., Kubota, S. and Nishida, T. (2003). Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell. Physiol. 194, 256-266.
108. Thannickal, V. J., Lee, D. Y., White, E. S., Cui, Z., Larjos, J. M., Chacon, R., Horowitz, J. C., Day, R. M. and Thomas, P. E. (2003). Myofibroblast differentiation by transforming growth factor-beta] is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278, 12384-12389.
109. Thiery, J. P. (2003). Cell adhesion in development: a complex signaling network. Curr Opin. Genet. Dev. 13, 365-371.
110. Todorovicc, V., Chen, C. C., Hay, N. and Lau, L. F. (2005). The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J Cell Biol. 171, 559-568.
111. van Beek, J., Kennedy, L., Rockel, J. S., Bernier, S. M. and Leask, A. (2006). The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res. Ther 8, R36.
112. Verrecchia, F., Vindevoghel, L., Lechleider, R. J., Uitto, J., Roberts, A. B. and Mauviel, A. (2001). Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene 20, 3332-3340.
113. Wahab, N. A., Weston, B. S. and Mason, R.M. (2005). Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J. Am. Soc. Nephrol. 16, 340-351.
114. Wong, M., Kireeva, M. L., Kolesnikova, T. V. and Lau, L. F. (1997). Cyr6 1, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev. Biol. 192, 492-508.
115. Yang, F., Tuxhorn, J. A., Ressler, S. J., McAlhany, S. J., Dang, T. D. and Rowley, D. R. (2005). Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 65, 8887-8895.
116. Zhang, Y., Pan, Q., Zhong, H., Merajver, S. D. and Meer, C. G. (2005). Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res. 7, R1080-R1089.
117. Zhao, J., Shi, W., Wang, Y. L., Chen, H., Bringas, P., Jr, Datto, M. B., Frederick, J. P., Wang, X. F. and Warburton, D. (2002). Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L585-L593.